Cardiovascular system disorders
20 results
Applied filters
Using calcium-channel blockers during breastfeeding
2 June 2023Nifedipine and verapamil are the calcium-channel blockers of choice during breastfeeding. Recommendations apply to full term and healthy infants only.
Using ACE inhibitors during breastfeeding
2 June 2023Enalapril is the angiotensin converting enzyme (ACE) inhibitor of choice during breastfeeding. Recommendations apply to full term and healthy infants only.
Using angiotensin-II receptor antagonists during breastfeeding
19 September 2023Very limited data suggest breastmilk levels are likely to be low, but other medicine classes are preferred. Recommendations apply to full term, healthy infants.
Heart failure: a primary care discussion
1 July 2026A practical discussion between two pharmacists about identifying heart failure and optimising treatment in primary care.
SMRs in problematic polypharmacy: cardiovascular disease focus
10 March 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with cardiovascular disease.
Commonly used medicines associated with QT interval prolongation
27 August 2026Examples of medicines known to prolong the QT interval. Medicines are grouped by therapeutic class and are not an exhaustive list.
Anticoagulant suggestions for adults with swallowing difficulties
9 September 2026A range of oral anticoagulant formulations are suitable for adults with swallowing difficulties.
Using beta-blockers during breastfeeding
9 August 2023Labetalol, metoprolol or propranolol are the beta-blockers of choice during breastfeeding. Recommendations apply to full term and healthy infants only.
Using clopidogrel with proton pump inhibitors (PPIs)
14 September 2023Avoid the combined use of clopidogrel with omeprazole or esomeprazole due to a significant interaction. Other PPIs are considered safe with clopidogrel.
ARB suggestions for adults with swallowing difficulties
20 June 2024A range of angiotensin II receptor antagonists (angiotensin receptor blockers, ARB) formulations are suitable for adults with swallowing difficulties.